---
title: ðŸ§® 1% Treaty Cost-Effectiveness
description: 1% Treaty + DIH + dFDA - Step-by-step calculation showing why this saves society $6.56 million per life saved
published: true
tags:
  - icer
  - cost-effectiveness
  - qaly
  - calculation
  - sensitivity-analysis
lastFactCheckHash: a3b5ed5c444e0871923ad5b3a9df93db7519e177fffab7aba8c22eac35bea6b3
jupyter: dih-project-kernel
---

```{python}
#| echo: false
# Import all economic parameters from centralized module
import sys
import os

# Quarto executes from project root (execute-dir: project in _quarto.yml)
# So we need to add brain/book/appendix to the path
appendix_path = os.path.join(os.getcwd(), 'brain', 'book', 'appendix')
if appendix_path not in sys.path:
    sys.path.insert(0, appendix_path)

from economic_parameters import *
```

## Executive Summary

**Bottom Line**: The 1% Treaty + DIH + dFDA Infrastructure is a **dominant health intervention** that saves society **`{python} format_currency(abs(COST_PER_LIFE_SAVED * 1_000_000_000))`** per life saved (ICER = **`{python} f"${ICER_PER_QALY * 1_000_000_000:,.0f}"`** per QALY).

This means for every life saved, society becomes **`{python} format_currency(abs(COST_PER_LIFE_SAVED * 1_000_000_000))`** richer instead of paying the [`{python} f"${GIVEWELL_COST_PER_LIFE_MIN:,.0f}-${GIVEWELL_COST_PER_LIFE_MAX:,.0f}"` cost of top charitable interventions](../references.qmd#givewell-cost-per-life-saved).

**How is this possible?** This initiative generates massive economic value (`{python} format_billions(TOTAL_ANNUAL_BENEFITS)` annually) while also saving lives (`{python} format_qalys(TOTAL_QALYS_ANNUAL)` QALYs annually), making it profitable for society to implement.

## Complete Calculation Walkthrough

### Step 1: Annual Economic Benefits

#### 1a. Peace Dividend (`{python} format_billions(SOCIETAL_DIVIDEND)`/year)

**Quick summary**: The 1% Treaty reduces global conflict by 1%, saving society `{python} format_billions(SOCIETAL_DIVIDEND)` annually from reduced military spending, infrastructure destruction, healthcare costs, and economic disruption.

**Calculation**: `{python} format_billions(TOTAL_WAR_COST)` total war costs Ã— `{python} format_percentage(TREATY_REDUCTION_PCT)` reduction = **`{python} format_billions(SOCIETAL_DIVIDEND)`**

**For detailed breakdown and methodology**, see:
- [Peace Dividend Calculations](peace-dividend-calculations.qmd) - Full Jupyter notebook with sensitivity analysis
- [Peace Dividend Chapter](../../economics/peace-dividend.qmd) - Accessible overview with breakdown table
- [Cost of War Analysis](../problem/cost-of-war.qmd) - Source data

#### 1b. Health Dividend (`{python} format_billions(DFDA_GROSS_SAVINGS)`/year)

**Quick summary**: The dFDA (Decentralized FDA) makes clinical trials 82Ã— cheaper by using the Oxford RECOVERY model, saving `{python} format_billions(DFDA_GROSS_SAVINGS)` annually from the `{python} format_billions(GLOBAL_TRIAL_MARKET)` global trial market.

**Calculation**: `{python} format_billions(GLOBAL_TRIAL_MARKET)` trial market Ã— `{python} format_percentage(TRIAL_COST_REDUCTION_PCT)` cost reduction = **`{python} format_billions(DFDA_GROSS_SAVINGS)`**

**ROI**: `{python} format_roi(ROI_TIER_1_CONSERVATIVE)` return on `{python} format_millions(DFDA_ANNUAL_OPEX)` annual operational cost

**For detailed breakdown and methodology**, see:
- [Health Dividend Calculations](health-dividend-calculations.qmd) - Full Jupyter notebook with NPV and ROI analysis
- [Health Dividend Chapter](../../economics/health-dividend.qmd) - Accessible overview with cost breakdown
- [dFDA Cost-Benefit Analysis](dfda-cost-benefit-analysis.qmd) - Detailed mechanism and QALY model

#### Total Annual Economic Benefits

**`{python} format_billions(SOCIETAL_DIVIDEND)` + `{python} format_billions(DFDA_GROSS_SAVINGS)` = `{python} format_billions(TOTAL_ANNUAL_BENEFITS)` per year**

**Sensitivity range**: $139B to $209B (conservative to optimistic scenarios)

---

### Step 2: Annual Health Benefits (QALYs)

#### 2a. Peace Dividend Health Benefits (`{python} format_qalys(PEACE_QALYS_ANNUAL)` QALYs/year)

**Source**: [Cost of War Analysis](../problem/cost-of-war.qmd#death-accounting)

**Annual conflict deaths**: `{python} format_qalys(ANNUAL_CONFLICT_DEATHS)` people/year

- Active combat: `{python} f"{CONFLICT_DEATHS_ACTIVE_COMBAT:,}"` ([ACLED data](https://acleddata.com/))
- Terror attacks: `{python} f"{CONFLICT_DEATHS_TERROR_ATTACKS:,}"` ([Global Terrorism Database](https://www.start.umd.edu/gtd/))
- State violence: `{python} f"{CONFLICT_DEATHS_STATE_VIOLENCE:,}"` ([Uppsala Conflict Data Program](https://ucdp.uu.se/))

**`{python} format_percentage(TREATY_REDUCTION_PCT)` reduction in conflict**:

- Lives saved: `{python} format_qalys(ANNUAL_CONFLICT_DEATHS)` Ã— `{python} TREATY_REDUCTION_PCT` = **`{python} format_qalys(PEACE_LIVES_SAVED_ANNUAL)` lives/year**

**Converting to QALYs**:

- Standard assumption: 1 life saved = `{python} QALYS_PER_LIFE` QALYs ([WHO life tables](https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-life-expectancy-and-healthy-life-expectancy))
- Rationale: Average age of conflict death ~30 years, life expectancy ~65 years = 35 years of life
- QALYs from peace dividend: `{python} format_qalys(PEACE_LIVES_SAVED_ANNUAL)` Ã— `{python} QALYS_PER_LIFE` = **`{python} format_qalys(PEACE_QALYS_ANNUAL)` QALYs/year**

**Sensitivity range**: 500-1,500 lives saved = 17,500-52,500 QALYs

#### 2b. dFDA Health Benefits (`{python} format_qalys(DFDA_QALYS_ANNUAL)` QALYs/year)

**Source**: [dFDA Cost-Benefit Analysis](dfda-cost-benefit-analysis.qmd#appendix-detailed-qaly-calculation-model)

**Baseline projection**: 840,000 QALYs/year from:

1. **Faster drug access** (50% of total): 420,000 QALYs
   - Average 2-3 year reduction in time to market
   - Applied to ~50 new drugs/year reaching market faster

2. **New therapies enabled** (30% of total): 252,000 QALYs
   - Rare diseases now economically viable
   - Unpatentable treatments tested
   - Repurposed drugs

3. **Prevention via real-world data** (20% of total): 168,000 QALYs
   - Early detection of drug interactions
   - Personalized medicine insights
   - Population health monitoring

**Sensitivity range**: 420,000 (conservative) to 2,100,000 (optimistic) QALYs

See [Appendix: Detailed QALY Calculation Model](dfda-cost-benefit-analysis.qmd#appendix-detailed-qaly-calculation-model) for complete methodology.

#### Total Annual Health Benefits

**`{python} format_qalys(PEACE_QALYS_ANNUAL)` + `{python} format_qalys(DFDA_QALYS_ANNUAL)` = `{python} format_qalys(TOTAL_QALYS_ANNUAL)` QALYs/year**

**Sensitivity range**: 437,500 (low) to 2,152,500 (high) QALYs

---

### Step 3: Annual Costs

#### 3a. Campaign Costs (`{python} format_currency(CAMPAIGN_ANNUAL_COST_AMORTIZED)`/year, amortized)

**Source**: [Campaign Budget](../economics/campaign-budget.qmd)

**Total campaign budget**: `{python} format_billions(CAMPAIGN_TOTAL_COST)` over `{python} CAMPAIGN_DURATION_YEARS`-5 years

- Viral referendum: `{python} format_currency(CAMPAIGN_BUDGET_VIRAL_REFERENDUM)`
- AI-assisted lobbying: `{python} format_currency(CAMPAIGN_BUDGET_AI_LOBBYING)`
- Technology platform: `{python} format_currency(CAMPAIGN_BUDGET_TECHNOLOGY)`
- Legal & compliance: `{python} format_currency(CAMPAIGN_BUDGET_LEGAL)`
- Partnerships: `{python} format_currency(CAMPAIGN_BUDGET_PARTNERSHIPS)`
- Operations: `{python} format_currency(CAMPAIGN_BUDGET_OPERATIONS)`
- Reserve: `{python} format_currency(CAMPAIGN_BUDGET_RESERVE)`

**Amortized annual cost**:

- Conservative (3 years): `{python} format_billions(CAMPAIGN_TOTAL_COST)` Ã· 3 = $333M/year
- Central (`{python} CAMPAIGN_DURATION_YEARS` years): `{python} format_billions(CAMPAIGN_TOTAL_COST)` Ã· `{python} CAMPAIGN_DURATION_YEARS` = **`{python} format_currency(CAMPAIGN_ANNUAL_COST_AMORTIZED)`/year**
- Optimistic (5 years): `{python} format_billions(CAMPAIGN_TOTAL_COST)` Ã· 5 = $200M/year

**Using central estimate**: **`{python} format_currency(CAMPAIGN_ANNUAL_COST_AMORTIZED)`/year**

**Note**: After initial 3-5 year campaign, these costs drop to near zero. We use amortized costs for a 10-year NPV analysis.

#### 3b. dFDA Operational Costs (`{python} format_currency(DFDA_ANNUAL_OPEX)`/year)

**Source**: [dFDA Cost-Benefit Analysis](dfda-cost-benefit-analysis.qmd#simplified-roi-scenario)

**Annual operational costs**: `{python} format_currency(DFDA_ANNUAL_OPEX)`/year

- Platform maintenance: `{python} format_currency(DFDA_OPEX_PLATFORM_MAINTENANCE)`
- Staff (minimal, AI-assisted): `{python} format_currency(DFDA_OPEX_STAFF)`
- Infrastructure (cloud, security): `{python} format_currency(DFDA_OPEX_INFRASTRUCTURE)`
- Regulatory coordination: `{python} format_currency(DFDA_OPEX_REGULATORY)`
- Community support: `{python} format_currency(DFDA_OPEX_COMMUNITY)`

**Sensitivity range**: $30M (efficient) to $60M (expanded operations)

#### Total Annual Costs

**`{python} format_currency(CAMPAIGN_ANNUAL_COST_AMORTIZED)` + `{python} format_currency(DFDA_ANNUAL_OPEX)` = `{python} format_currency(TOTAL_ANNUAL_COSTS)`/year**

**Sensitivity range**: $230M to $393M

---

### Step 3b: Alternative Cost Perspective - The Funding Mechanism

**Important Note**: The above calculation uses traditional health economics methodology, counting all upfront costs. However, the actual funding mechanism makes the true cost perspective more nuanced.

#### Understanding the Funding Flow

**The DIH Treasury Mechanism**:

1. **Countries redirect `{python} format_billions(DIH_TREASURY_MILITARY_REDIRECT)`/year** from military budgets to the DIH treasury
2. **The DIH treasury allocates**:
   - `{python} format_billions(DIH_TREASURY_TO_VICTORY_BONDS)`/year â†’ VICTORY bondholders (`{python} format_percentage(VICTORY_BOND_FUNDING_PCT)}` of redirected funds)
   - `{python} format_billions(DIH_TREASURY_TO_RESEARCH)`/year â†’ Medical research and operations
   - This `{python} format_billions(DIH_TREASURY_TO_RESEARCH)` covers:
     - dFDA operations: `{python} format_currency(DIH_TREASURY_DFDA_OPERATIONS)`/year
     - Clinical trial subsidies: ~`{python} format_billions(DIH_TREASURY_TRIAL_SUBSIDIES_MIN)`-`{python} format_billions(DIH_TREASURY_TRIAL_SUBSIDIES_MAX)`/year
     - Other medical research: Remaining funds

**VICTORY Bond Financing**:

- **Investors provide**: `{python} format_billions(CAMPAIGN_TOTAL_COST)` upfront (funds the campaign)
- **Investors receive**: `{python} format_billions(VICTORY_BOND_ANNUAL_PAYOUT)`/year perpetually (`{python} format_percentage(VICTORY_BOND_ANNUAL_RETURN_PCT)` annual return)
- **Payback period**: 4.4 months
- **Result**: Campaign is self-funding from investor perspective

#### Alternative Cost Framings

**Framing 1: Zero Upfront Cost (Investor-Funded)**

- Campaign cost: $0 (funded by VICTORY bond investors who get repaid)
- dFDA operations: $0 (funded by DIH treasury from redirected military spending)
- **Total cost to society: $0/year**
- **ICER = -$168,114 per QALY** (society pays nothing, gets everything)

**Framing 2: Opportunity Cost of Redirected Spending**

- Cost: `{python} format_billions(CAPTURED_DIVIDEND)`/year (redirected military spending)
- But this `{python} format_billions(CAPTURED_DIVIDEND)` is ALREADY COUNTED in the `{python} format_billions(SOCIETAL_DIVIDEND)` peace dividend
- Net cost: `{python} format_billions(CAPTURED_DIVIDEND)` - `{python} format_billions(CAPTURED_DIVIDEND)` = $0
- **ICER = -$187,543 per QALY**

**Framing 3: Military Waste Conversion**

- Military spending has negative ROI (destroys value)
- Medical spending has positive ROI (creates value)
- We're converting waste into productive investment
- **True cost: Negative** (we're avoiding wasteful spending)
- **ICER = Undefined** (negative cost, positive QALYs)

#### Why We Use Conservative `{python} format_millions(TOTAL_ANNUAL_COSTS)`/Year in Primary Analysis

**For credibility and conservative estimation**:

1. Health economics convention requires counting all costs
2. Someone must pay the `{python} format_billions(CAMPAIGN_TOTAL_COST)` campaign cost initially (even if repaid)
3. Conservative estimates are more defensible to skeptics
4. This intervention is dominant even with costs included

**Key insight**: Even counting ALL costs conservatively, the ICER is -$167,771/QALY. Under more realistic framings where the campaign is self-funding, the true societal cost approaches $0, making the intervention infinitely cost-effective.

---

### Step 4: ICER Calculation

**ICER (Incremental Cost-Effectiveness Ratio)** = (Costs - Benefits) / QALYs gained

#### 4a. Net Economic Impact

**Annual net benefit** = Benefits - Costs

- Benefits: `{python} format_billions(TOTAL_ANNUAL_BENEFITS)`
- Costs: `{python} format_currency(TOTAL_ANNUAL_COSTS)`
- **Net benefit: `{python} format_billions(NET_ANNUAL_BENEFIT)` per year**

**Society saves `{python} format_billions(NET_ANNUAL_BENEFIT)` while gaining `{python} format_qalys(TOTAL_QALYS_ANNUAL)` QALYs**

#### 4b. ICER per QALY

**ICER** = (`{python} format_currency(TOTAL_ANNUAL_COSTS)` - `{python} format_billions(TOTAL_ANNUAL_BENEFITS)`) / `{python} format_qalys(TOTAL_QALYS_ANNUAL)` QALYs

**ICER** = `{python} f"${(TOTAL_ANNUAL_COSTS - TOTAL_ANNUAL_BENEFITS)*1000:,.1f}M"` / `{python} format_qalys(TOTAL_QALYS_ANNUAL)`

**ICER = `{python} f"${ICER_PER_QALY * 1_000_000_000:,.0f}"` per QALY**

**Interpretation**: For every QALY gained, society saves `{python} f"${abs(ICER_PER_QALY * 1_000_000_000):,.0f}"`. This is a **dominant intervention** (saves money AND improves health).

#### 4c. Cost per Life Saved

**Cost per life** = ICER Ã— QALYs per life

**Cost per life** = `{python} f"${ICER_PER_QALY * 1_000_000_000:,.0f}"`  Ã— `{python} QALYS_PER_LIFE` QALYs/life

**Cost per life â‰ˆ `{python} format_currency(abs(COST_PER_LIFE_SAVED * 1_000_000_000))` per life saved**

**Interpretation**: For every life saved, society saves approximately `{python} format_currency(abs(COST_PER_LIFE_SAVED * 1_000_000_000))}`.

---

## Comparison to Other Interventions

### [Top Charitable Interventions (GiveWell 2024)](../references.qmd#givewell-cost-per-life-saved)

| Intervention | Cost per Life Saved | ICER (approx) |
|-------------|--------------------:|---------------:|
| **Helen Keller International** (Vitamin A) | `{python} f"${GIVEWELL_COST_PER_LIFE_MIN:,.0f}"` | $100/QALY |
| **New Incentives** (Vaccination incentives) | `{python} f"${GIVEWELL_COST_PER_LIFE_AVG:,.0f}"` | $129/QALY |
| **Against Malaria Foundation** (bed nets) | `{python} f"${GIVEWELL_COST_PER_LIFE_MAX:,.0f}"` | $157/QALY |

**Source**: [GiveWell 2024 Top Charities](https://www.givewell.org/how-much-does-it-cost-to-save-a-life/february-2024-version)

These are **excellent** interventions - among the best uses of charitable dollars. They cost society money but save lives very cost-effectively.

### 1% Treaty + DIH + dFDA

| Intervention | Cost per Life Saved | ICER |
|-------------|--------------------:|------:|
| **1% Treaty + DIH + dFDA** | **`{python} format_currency(COST_PER_LIFE_SAVED * 1_000_000_000)`** | **`{python} f"${ICER_PER_QALY * 1_000_000_000:,.0f}"`/QALY** |

This is a **dominant intervention** - it makes society richer while saving lives.

### The Difference

**Traditional charity model**: Society pays to save lives

- Excellent value (`{python} f"${GIVEWELL_COST_PER_LIFE_MIN:,.0f}-${GIVEWELL_COST_PER_LIFE_MAX:,.0f}"` per life)
- Requires ongoing donations
- Costs money to implement

**1% Treaty model**: Society profits from saving lives

- Exceptional value (`{python} format_currency(COST_PER_LIFE_SAVED * 1_000_000_000)` per life = society saves money)
- Self-funding from economic gains
- Generates wealth while improving health

**The multiplier**: The 1% Treaty is **`{python} f"{MULTIPLIER_VS_GIVEWELL:,.0f}x"` more cost-effective** than the best charities in the world.

---

## Sensitivity Analysis

### Key Parameters and Ranges

| Parameter | Conservative | Central | Optimistic |
|-----------|-------------:|--------:|------------:|
| **Peace dividend** | `{python} format_billions(SENSITIVITY_PEACE_DIVIDEND_CONSERVATIVE)` | `{python} format_billions(SENSITIVITY_PEACE_DIVIDEND_CENTRAL)` | `{python} format_billions(SENSITIVITY_PEACE_DIVIDEND_OPTIMISTIC)` |
| **dFDA R&D savings** | `{python} format_billions(SENSITIVITY_DFDA_SAVINGS_CONSERVATIVE)` | `{python} format_billions(SENSITIVITY_DFDA_SAVINGS_CENTRAL)` | `{python} format_billions(SENSITIVITY_DFDA_SAVINGS_OPTIMISTIC)` |
| **Total benefits** | `{python} format_billions(SENSITIVITY_TOTAL_BENEFITS_CONSERVATIVE)` | `{python} format_billions(SENSITIVITY_TOTAL_BENEFITS_CENTRAL)` | `{python} format_billions(SENSITIVITY_TOTAL_BENEFITS_OPTIMISTIC)` |
| **Campaign costs/yr** | `{python} format_currency(SENSITIVITY_CAMPAIGN_COST_CONSERVATIVE)` | `{python} format_currency(SENSITIVITY_CAMPAIGN_COST_CENTRAL)` | `{python} format_currency(SENSITIVITY_CAMPAIGN_COST_OPTIMISTIC)` |
| **dFDA ops costs/yr** | `{python} format_currency(SENSITIVITY_DFDA_OPEX_CONSERVATIVE)` | `{python} format_currency(SENSITIVITY_DFDA_OPEX_CENTRAL)` | `{python} format_currency(SENSITIVITY_DFDA_OPEX_OPTIMISTIC)` |
| **Total costs/yr** | `{python} format_currency(SENSITIVITY_TOTAL_COSTS_CONSERVATIVE)` | `{python} format_currency(SENSITIVITY_TOTAL_COSTS_CENTRAL)` | `{python} format_currency(SENSITIVITY_TOTAL_COSTS_OPTIMISTIC)` |
| **Peace QALYs** | `{python} format_qalys(SENSITIVITY_PEACE_QALYS_CONSERVATIVE)` | `{python} format_qalys(SENSITIVITY_PEACE_QALYS_CENTRAL)` | `{python} format_qalys(SENSITIVITY_PEACE_QALYS_OPTIMISTIC)` |
| **dFDA QALYs** | `{python} format_qalys(SENSITIVITY_DFDA_QALYS_CONSERVATIVE)` | `{python} format_qalys(SENSITIVITY_DFDA_QALYS_CENTRAL)` | `{python} format_qalys(SENSITIVITY_DFDA_QALYS_OPTIMISTIC)` |
| **Total QALYs** | `{python} format_qalys(SENSITIVITY_TOTAL_QALYS_CONSERVATIVE)` | `{python} format_qalys(SENSITIVITY_TOTAL_QALYS_CENTRAL)` | `{python} format_qalys(SENSITIVITY_TOTAL_QALYS_OPTIMISTIC)` |

### ICER Across Scenarios

| Scenario | Net Benefit | QALYs | ICER/QALY | Cost/Life |
|----------|------------:|------:|-----------:|----------:|
| **Conservative** | `{python} format_billions(SENSITIVITY_NET_BENEFIT_CONSERVATIVE)` | `{python} format_qalys(SENSITIVITY_TOTAL_QALYS_CONSERVATIVE)` | **`{python} f"${SENSITIVITY_ICER_CONSERVATIVE:,.0f}"`** | **`{python} f"${SENSITIVITY_COST_PER_LIFE_CONSERVATIVE:.2f}M"`** |
| **Central** | `{python} format_billions(SENSITIVITY_NET_BENEFIT_CENTRAL)` | `{python} format_qalys(SENSITIVITY_TOTAL_QALYS_CENTRAL)` | **`{python} f"${SENSITIVITY_ICER_CENTRAL:,.0f}"`** | **`{python} f"${SENSITIVITY_COST_PER_LIFE_CENTRAL:.2f}M"`** |
| **Optimistic** | `{python} format_billions(SENSITIVITY_NET_BENEFIT_OPTIMISTIC)` | `{python} format_qalys(SENSITIVITY_TOTAL_QALYS_OPTIMISTIC)` | **`{python} f"${SENSITIVITY_ICER_OPTIMISTIC:,.0f}"`** | **`{python} f"${SENSITIVITY_COST_PER_LIFE_OPTIMISTIC:.2f}M"`** |

**Key finding**: In ALL scenarios, the intervention is dominant (saves money while saving lives).

### Alternative ICER Calculations Based on Funding Perspective

| Perspective | Annual Cost | Annual Benefit | QALYs | ICER/QALY | Cost/Life | Notes |
|-------------|------------:|---------------:|------:|----------:|----------:|-------|
| **Conservative (All Costs)** | `{python} format_currency(SENSITIVITY_TOTAL_COSTS_CENTRAL)` | `{python} format_billions(SENSITIVITY_TOTAL_BENEFITS_CENTRAL)` | `{python} f"{int(SENSITIVITY_TOTAL_QALYS_CENTRAL/1000)}k"` | **`{python} f"${ICER_CONSERVATIVE_ALL_COSTS:,.0f}"`** | **`{python} f"${COST_PER_LIFE_CONSERVATIVE_ALL_COSTS:.2f}M"`** | Counts all upfront costs |
| **Investor-Funded** | $0 | `{python} format_billions(SENSITIVITY_TOTAL_BENEFITS_CENTRAL)` | `{python} f"{int(SENSITIVITY_TOTAL_QALYS_CENTRAL/1000)}k"` | **`{python} f"${ICER_INVESTOR_FUNDED:,.0f}"`** | **`{python} f"${COST_PER_LIFE_INVESTOR_FUNDED:.2f}M"`** | Campaign funded by VICTORY bonds |
| **Opportunity Cost** | `{python} format_billions(DIH_TREASURY_MILITARY_REDIRECT)` | `{python} format_billions(SENSITIVITY_TOTAL_BENEFITS_CENTRAL)` | `{python} f"{int(SENSITIVITY_TOTAL_QALYS_CENTRAL/1000)}k"` | **`{python} f"${ICER_OPPORTUNITY_COST:,.0f}"`** | **`{python} f"${COST_PER_LIFE_OPPORTUNITY_COST:.2f}M"`** | Counts redirected military spending |
| **Waste Conversion** | `{python} f"-{format_billions(DIH_TREASURY_MILITARY_REDIRECT)}*"` | `{python} format_billions(SENSITIVITY_TOTAL_BENEFITS_CENTRAL)` | `{python} f"{int(SENSITIVITY_TOTAL_QALYS_CENTRAL/1000)}k"` | **Undefined** | **Undefined** | Military spending creates negative value |

*Military spending has negative ROI (destroys value), so redirecting it is a benefit, not a cost.

**Interpretation**:

- Under traditional health economics (Conservative), the ICER is -$167,771/QALY
- Under realistic funding (Investor-Funded), society pays $0, ICER approaches -âˆž
- Considering opportunity cost of military spending, ICER is -$137,257/QALY
- Recognizing military spending as waste, the intervention has undefined (infinite) cost-effectiveness

**Worst case** (conservative): Society still saves $5.97M per life saved

**Best case** (optimistic): Society saves $4.79M per life saved (lower because we're saving many more lives, so the economic benefit is spread across more QALYs)

---

## Visual Comparisons

### Cost-Effectiveness: How Much Does Society Pay to Save a Life?

{{< include ../../../brain/figures/philanthropic-cost-effectiveness-comparison-bar-chart.qmd >}}

This chart demonstrates the fundamental difference between traditional philanthropy and the 1% Treaty approach:

- **GiveWell Top Charities** (Helen Keller International, New Incentives, Against Malaria Foundation): Society pays $3,500-$5,500 per life saved. These are excellent interventionsâ€”among the most cost-effective charitable uses of money in the world.

- **1% Treaty + DIH + dFDA**: Society SAVES $6.56 million per life saved. This is a dominant intervention that generates wealth while saving lives. The stacked bar shows contributions from both the peace dividend (1% less conflict) and dFDA R&D savings.

The dramatic scale difference illustrates why this intervention is ~1,700Ã— more cost-effective than even the best traditional charities.

### Scale of Impact: Annual Economic Benefits

{{< include ../../../brain/figures/health-programs-vs-1-percent-treaty-societal-benefits-bar-chart.qmd >}}

This chart compares the gross annual economic benefits across major public health interventions:

- **Traditional interventions** (Water Fluoridation, Smoking Cessation, Childhood Vaccinations): Generate $0.8B to $15B in annual economic benefits. These are highly successful programs that have transformed public health.

- **1% Treaty + DIH + dFDA**: Generates `{python} format_billions(TOTAL_ANNUAL_BENEFITS)` in annual economic benefits (`{python} format_billions(SOCIETAL_DIVIDEND)` peace dividend + `{python} format_billions(DFDA_GROSS_SAVINGS)` dFDA R&D savings). This is nearly 11Ã— larger than childhood vaccinations, one of the most successful interventions in history.

**Key distinction**: Only the 1% Treaty is self-fundingâ€”it generates the wealth needed to sustain itself while traditional interventions require ongoing funding.

---

### Monte Carlo Simulation (Recommended)

For publication-quality analysis, we recommend running a Monte Carlo simulation with:

- 10,000 iterations
- Probability distributions for each parameter
- Correlation analysis between variables
- 95% confidence intervals

**Preliminary Monte Carlo results** (if available): [Link to sensitivity analysis notebook]

---

## Sources and References

### Economic Benefits

1. **Peace Dividend**: [Peace Dividend Calculations](peace-dividend-calculations.qmd)
   - Based on [Cost of War Analysis](../problem/cost-of-war.qmd)
   - Total war costs: `{python} format_billions(TOTAL_WAR_COST)` annually
   - 1% reduction: `{python} format_billions(SOCIETAL_DIVIDEND)`

2. **Health Dividend (dFDA)**: [Health Dividend Calculations](health-dividend-calculations.qmd)
   - Clinical trial market: ~`{python} format_billions(GLOBAL_TRIAL_MARKET)`/year
   - 50% cost reduction (baseline)
   - Range: 25%-95%
   - Also see: [dFDA Cost-Benefit Analysis](dfda-cost-benefit-analysis.qmd)

### Health Benefits

3. **Conflict Deaths**: [Cost of War Analysis](../problem/cost-of-war.qmd#death-accounting)
   - 100,000 deaths/year
   - Sources: ACLED, GTD, Uppsala

4. **dFDA QALYs**: [dFDA QALY Model](dfda-cost-benefit-analysis.qmd#appendix-detailed-qaly-calculation-model)
   - Baseline: 840,000 QALYs/year
   - Range: 420,000-2,100,000

5. **QALY Conversion**: WHO life tables
   - 1 life saved â‰ˆ 35 QALYs (standard assumption)

### Costs

6. **Campaign Budget**: [Campaign Budget](../economics/campaign-budget.qmd)
   - Total: $1B over 3-5 years
   - Amortized: $200-333M/year

7. **dFDA Operations**: [dFDA Cost Analysis](dfda-cost-benefit-analysis.qmd#simplified-roi-scenario)
   - Annual: `{python} format_millions(DFDA_ANNUAL_OPEX)`/year
   - Range: $30-60M

### Comparisons

8. **GiveWell Top Charities**: [GiveWell 2024](https://www.givewell.org/how-much-does-it-cost-to-save-a-life)
   - Cost per life: $3,000-$5,500
   - Data as of February 2024

---

## Frequently Asked Questions

### Q: How can this save money while saving lives?

**A**: The 1% Treaty generates `{python} format_billions(TOTAL_ANNUAL_BENEFITS)` in annual economic benefits:

- `{python} format_billions(SOCIETAL_DIVIDEND)` from reduced conflict costs (peace dividend)
- `{python} format_billions(DFDA_GROSS_SAVINGS)` from more efficient medical R&D (dFDA)

These benefits far exceed the `{python} format_millions(TOTAL_ANNUAL_COSTS)` annual costs, creating a net profit of `{python} format_billions(NET_ANNUAL_BENEFIT)`/year for society.

Meanwhile, the same initiative saves lives:

- 1,000 lives from 1% less conflict
- 840,000 QALYs from faster/better medical treatments

You get **both** the economic benefit **and** the health benefit.

### Q: Why isn't everyone doing this already?

**A**: Market failure and collective action problem:

- Individual countries can't capture the global benefits
- Defense contractors profit from the status quo
- No mechanism exists to coordinate global action
- Medical research funding is fragmented across countries

The 1% Treaty solves this by creating aligned incentives.

### Q: What's the catch?

**A**: The main challenges are **political, not economic**:

- Getting countries to sign the treaty (hence the `{python} format_billions(CAMPAIGN_TOTAL_COST)` campaign)
- Overcoming defense industry opposition (hence VICTORY bonds to co-opt them)
- Building the dFDA infrastructure (hence the $250M technology budget)

The math works. The challenge is execution.

### Q: How confident are you in these numbers?

**A**: Central estimates are conservative:

- Peace dividend uses 1% (could be 2-5% over time)
- dFDA uses 50% R&D savings (Oxford RECOVERY showed 80-100Ã—)
- Excludes many hard-to-quantify benefits (innovation, rare diseases, etc.)

**Even in worst-case scenarios** (conservative column), the ICER is still -$170,514/QALY.

The intervention is **robustly dominant** across all reasonable parameter ranges.

### Q: Is it misleading to say society pays $0 when the campaign is investor-funded?

**A**: This depends on perspective:

**From society's aggregate perspective**: The `{python} format_billions(CAMPAIGN_TOTAL_COST)` campaign cost is real money that someone must provide initially. However, since investors get repaid with `{python} format_percentage(VICTORY_BOND_ANNUAL_RETURN_PCT)` returns from redirected military spending, the net cost to society approaches $0 after payback.

**From taxpayers' perspective**: They give up `{python} format_billions(CAPTURED_DIVIDEND)` in military spending but receive `{python} format_billions(TOTAL_ANNUAL_BENEFITS)` in economic benefits (peace dividend + R&D savings). Net gain: $137B.

**From investors' perspective**: They invest $1B and receive $2.7B/year perpetually. This is the best investment in history.

**The key insight**: Traditional ICER assumes spending society's resources on health interventions. Here, we're redirecting resources from **destructive uses** (war) to **productive uses** (medical research). The "cost" is really just stopping waste.

### Q: Isn't redirecting military spending politically impossible?

**A**: That's what the `{python} format_billions(CAMPAIGN_TOTAL_COST)` campaign budget is for - making the politically impossible become inevitable through:

- Viral referendum showing overwhelming public support (80%+ want less war, more cures)
- VICTORY bonds that make supporting the treaty more profitable than opposing it
- AI-assisted lobbying that's 60-80% more cost-effective than traditional campaigns
- Creating unstoppable momentum in pilot countries first

The math shows it's worth trying. Even a 10% chance of success has positive expected value given the enormous returns.

---

## Next Steps

1. **Validate assumptions**: External review of cost estimates
2. **Monte Carlo analysis**: Full probabilistic sensitivity analysis
3. **Peer review**: Submit to health economics journals
4. **Policy brief**: One-page summary for decision-makers
5. **Interactive calculator**: Let users adjust assumptions

## Related Analyses

**Detailed Calculations**:
- [Peace Dividend Calculations](peace-dividend-calculations.qmd) - Full analysis of conflict reduction benefits
- [Health Dividend Calculations](health-dividend-calculations.qmd) - Full analysis of dFDA R&D savings
- [dFDA Cost-Benefit Analysis](dfda-cost-benefit-analysis.qmd) - Detailed QALY model and mechanism

**Accessible Overviews**:
- [Peace Dividend Chapter](../../economics/peace-dividend.qmd) - Accessible summary with breakdown table
- [Health Dividend Chapter](../../economics/health-dividend.qmd) - Accessible summary with ROI story

**Other References**:
- [Campaign Budget](../../economics/campaign-budget.qmd) - Detailed cost breakdown
- [Intervention Comparison Table](intervention-comparison-table.qmd) - Compare to other health interventions
